Mouse Anti-CES2 Recombinant Antibody (CBFYC-1734) (CBMAB-C1796-FY)

Xu, Y., Pan, X., Hu, S., Zhu, Y., Cassim Bawa, F., Li, Y., ... & Zhang, Y. (2021). Hepatocyte-specific expression of human carboxylesterase 2 attenuates nonalcoholic steatohepatitis in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology, 320(2), G166-G174.

Shen, Y., Eades, W., & Yan, B. (2021). Remdesivir potently inhibits carboxylesterase‐2 through covalent modifications: signifying strong drug‐drug interactions. Fundamental & Clinical Pharmacology, 35(2), 432-434.

Chalhoub, G., Kolleritsch, S., Maresch, L. K., Taschler, U., Pajed, L., Tilp, A., ... & Haemmerle, G. (2021). Carboxylesterase 2 proteins are efficient diglyceride and monoglyceride lipases possibly implicated in metabolic disease. Journal of lipid research, 62.

Song, Y. Q., He, R. J., Pu, D., Guan, X. Q., Shi, J. H., Li, Y. G., ... & Ge, G. B. (2021). Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2. Frontiers in pharmacology, 12.

Qian, X. K., Zhang, J., Song, P. F., Zhao, Y. S., Ma, H. Y., Jin, Q., ... & Zou, L. W. (2021). Discovery of pyrazolones as novel carboxylesterase 2 inhibitors that potently inhibit the adipogenesis in cells. Bioorganic & Medicinal Chemistry, 40, 116187.

Tian, X., Yan, F., Zheng, J., Cui, X., Feng, L., Li, S., ... & Ma, X. (2019). Endoplasmic reticulum targeting ratiometric fluorescent probe for carboxylesterase 2 detection in drug-induced acute liver injury. Analytical chemistry, 91(24), 15840-15845.

Yi, J., Bai, R., An, Y., Liu, T. T., Liang, J. H., Tian, X. G., ... & Zhang, H. L. (2019). A natural inhibitor from Alisma orientale against human carboxylesterase 2: kinetics, circular dichroism spectroscopic analysis, and docking simulation. International journal of biological macromolecules, 133, 184-189.

Zhao, Y. S., Ruan, H. L., Wang, X. Y., Chen, C., Song, P. F., Lü, C. W., & Zou, L. W. (2019). Catalyst-free visible-light-induced condensation to synthesize bis (indolyl) methanes and biological activity evaluation of them as potent human carboxylesterase 2 inhibitors. RSC Advances, 9(68), 40168-40175.

Ruby, M. A., Massart, J., Hunerdosse, D. M., Schönke, M., Correia, J. C., Louie, S. M., ... & Zierath, J. R. (2017). Human carboxylesterase 2 reverses obesity-induced diacylglycerol accumulation and glucose intolerance. Cell reports, 18(3), 636-646.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols